SCHEMBL22308985

SCHEMBL22308985

CC1(C)c2cc(-c3cc(-c4cccc(-c5cccc(-c6nc(-c7cccc8ccccc78)nc(-c7cccc8ccccc78)n6)c5)c4)nc(-c4ccccc4)n3)ccc2-c2cc3ccccc3cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
MAPT P10636 4/20 0.41
HPGD P15428 4/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
KDM4E B2RXH2 3/20 0.41
LMNA P02545 2/20 0.41
GLA P06280 1/20 0.41
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
ATM Q13315 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PDK2 Q15119 7/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22308667 0.93 ALDH1A1 (0.40) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL22309426 0.92 MEN1 (0.48) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL22309550 0.91 MEN1 (0.40) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL25538797 0.91 ENPP3 (0.38) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL22309554 0.91 MEN1 (0.45) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL22309551 0.91 MEN1 (0.45) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL22308669 0.91 MEN1 (0.47) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL22308919 0.91 MEN1 (0.50) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL22308661 0.91 MEN1 (0.47) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL22309427 0.91 MEN1 (0.50) ALDH1A1MAPTHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 US disclosed
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 US disclosed
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME VDAC1, OR10J3, PIEZO1 ALDH1A1 644/4885MAPT 660/4885HPGD 3640/4885
US-11917910-B2 Organic compound and organic electroluminescent device using the same VDAC1, OR10J3, PIEZO1 ALDH1A1 644/4885MAPT 660/4885HPGD 3640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.